APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ampicillin

Ampicillin is semisynthetic penicillin and a ß-lactam antibiotic, with Antimicrobial Spectrum of Effective against both Gram-positive (similar to benzylpenicillin) and Gram-negative bacteria (similar to tetracyclines and chloramphenicol).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Ampicillin is semisynthetic penicillin and a ß-lactam antibiotic, with Antimicrobial Spectrum of Effective against both Gram-positive (similar to benzylpenicillin) and Gram-negative bacteria (similar to tetracyclines and chloramphenicol).

Selected research

Market Outlook & Growth Opportunities

Global Ampicillin Market Outlook and Growth Opportunities 2026

26 December 2025196 pages

Choose your research edition.

Industry ResearchAmpicillin Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Ampicillin Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Ampicillin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ampicillin Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Ampicillin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Ampicillin is semisynthetic penicillin and a ß-lactam antibiotic, with Antimicrobial Spectrum of Effective against both Gram-positive (similar to benzylpenicillin) and Gram-negative bacteria (similar to tetracyclines and chloramphenicol).

China is the largest region of Ampicillin, with a market share nearly 70%. DSM, United Laboratories, CSPC Pharmaceutical, North China Pharmaceutical and Huaxing Pharmaceutical are the top 5 manufacturers of industry, and they had about 70% combined market share.

This report provides an overview of the global Ampicillin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Ampicillin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ampicillin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ampicillin market size, projected growth trends, production technologies, key applications, and end-use industries.

Ampicillin Segment by Company

DSM

ACS Dobfar

Kopran

Antibioticos

United Laboratories

Shandong Lukang

CSPC Pharmaceutical

North China Pharmaceutical

Huaxing Pharmaceutical

Ampicillin Segment by Type

Ampicillin Capsules

Ampicillin Sodium

Ampicillin Granules

Ampicillin Tablets

Ampicillin Sodium for Injection

Ampicillin Sodium and Sulbactam Sodium for Injection

Ampicillin Sodium and Cloxacillin Sodium for Injection

Others

Ampicillin Segment by Application

Adults

Kids

Ampicillin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ampicillin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ampicillin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ampicillin significant trends, drivers, influence factors in global and regions.

6. To analyze Ampicillin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ampicillin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ampicillin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ampicillin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ampicillin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ampicillin industry.

Chapter 3: Detailed analysis of Ampicillin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ampicillin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ampicillin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ampicillin Industry Trends Table 2. Ampicillin Industry Drivers Table 3. Ampicillin Industry Opportunities and Challenges Table 4. Ampicillin Industry Restraints Table 5. Global Ampicillin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ampicillin Revenue Share by Company (2021-2026) Table 7. Global Ampicillin Sales Volume by Company (t) & (2021-2026) Table 8. Global Ampicillin Sales Volume Share by Company (2021-2026) Table 9. Global Ampicillin Average Price (USD/kg) of Company (2021-2026) Table 10. Global Ampicillin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ampicillin Key Company Manufacturing Base & Headquarters Table 12. Global Ampicillin Company, Product Type & Application Table 13. Global Ampicillin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ampicillin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Ampicillin Capsules Table 18. Significant Companies of Ampicillin Sodium Table 19. Significant Companies of Ampicillin Granules Table 20. Significant Companies of Ampicillin Tablets Table 21. Significant Companies of Ampicillin Sodium for Injection Table 22. Significant Companies of Ampicillin Sodium and Sulbactam Sodium for Injection Table 23. Significant Companies of Ampicillin Sodium and Cloxacillin Sodium for Injection Table 24. Significant Companies of Others Table 25. Global Ampicillin Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 26. Global Ampicillin Sales Volume by Type (2021-2026) & (t) Table 27. Global Ampicillin Sales Volume by Type (2027-2032) & (t) Table 28. Global Ampicillin Sales Volume Share by Type (2021-2026) Table 29. Global Ampicillin Sales Volume Share by Type (2027-2032) Table 30. Global Ampicillin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Ampicillin Sales Value by Type (2021-2026) & (US$ Million) Table 32. Global Ampicillin Sales Value by Type (2027-2032) & (US$ Million) Table 33. Global Ampicillin Sales Value Share by Type (2021-2026) Table 34. Global Ampicillin Sales Value Share by Type (2027-2032) Table 35. Significant Companies of Adults Table 36. Significant Companies of Kids Table 37. Global Ampicillin Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 38. Global Ampicillin Sales Volume by Application (2021-2026) & (t) Table 39. Global Ampicillin Sales Volume by Application (2027-2032) & (t) Table 40. Global Ampicillin Sales Volume Share by Application (2021-2026) Table 41. Global Ampicillin Sales Volume Share by Application (2027-2032) Table 42. Global Ampicillin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Ampicillin Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Ampicillin Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Ampicillin Sales Value Share by Application (2021-2026) Table 46. Global Ampicillin Sales Value Share by Application (2027-2032) Table 47. Global Ampicillin Sales by Region: 2021 VS 2025 VS 2032 (t) Table 48. Global Ampicillin Sales by Region (2021-2026) & (t) Table 49. Global Ampicillin Sales Market Share by Region (2021-2026) Table 50. Global Ampicillin Sales by Region (2027-2032) & (t) Table 51. Global Ampicillin Sales Market Share by Region (2027-2032) Table 52. Global Ampicillin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Ampicillin Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Ampicillin Sales Value Share by Region (2021-2026) Table 55. Global Ampicillin Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Ampicillin Sales Value Share by Region (2027-2032) Table 57. Global Ampicillin Market Average Price (USD/kg) by Region (2021-2026) Table 58. Global Ampicillin Market Average Price (USD/kg) by Region (2027-2032) Table 59. Global Ampicillin Sales by Country: 2021 VS 2025 VS 2032 (t) Table 60. Global Ampicillin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Ampicillin Sales by Country (2021-2026) & (t) Table 62. Global Ampicillin Sales Market Share by Country (2021-2026) Table 63. Global Ampicillin Sales by Country (2027-2032) & (t) Table 64. Global Ampicillin Sales Market Share by Country (2027-2032) Table 65. Global Ampicillin Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Ampicillin Sales Value Market Share by Country (2021-2026) Table 67. Global Ampicillin Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Ampicillin Sales Value Market Share by Country (2027-2032) Table 69. DSM Company Information Table 70. DSM Business Overview Table 71. DSM Ampicillin Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 72. DSM Ampicillin Product Portfolio Table 73. DSM Recent Development Table 74. ACS Dobfar Company Information Table 75. ACS Dobfar Business Overview Table 76. ACS Dobfar Ampicillin Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 77. ACS Dobfar Ampicillin Product Portfolio Table 78. ACS Dobfar Recent Development Table 79. Kopran Company Information Table 80. Kopran Business Overview Table 81. Kopran Ampicillin Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 82. Kopran Ampicillin Product Portfolio Table 83. Kopran Recent Development Table 84. Antibioticos Company Information Table 85. Antibioticos Business Overview Table 86. Antibioticos Ampicillin Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 87. Antibioticos Ampicillin Product Portfolio Table 88. Antibioticos Recent Development Table 89. United Laboratories Company Information Table 90. United Laboratories Business Overview Table 91. United Laboratories Ampicillin Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 92. United Laboratories Ampicillin Product Portfolio Table 93. United Laboratories Recent Development Table 94. Shandong Lukang Company Information Table 95. Shandong Lukang Business Overview Table 96. Shandong Lukang Ampicillin Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 97. Shandong Lukang Ampicillin Product Portfolio Table 98. Shandong Lukang Recent Development Table 99. CSPC Pharmaceutical Company Information Table 100. CSPC Pharmaceutical Business Overview Table 101. CSPC Pharmaceutical Ampicillin Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 102. CSPC Pharmaceutical Ampicillin Product Portfolio Table 103. CSPC Pharmaceutical Recent Development Table 104. North China Pharmaceutical Company Information Table 105. North China Pharmaceutical Business Overview Table 106. North China Pharmaceutical Ampicillin Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 107. North China Pharmaceutical Ampicillin Product Portfolio Table 108. North China Pharmaceutical Recent Development Table 109. Huaxing Pharmaceutical Company Information Table 110. Huaxing Pharmaceutical Business Overview Table 111. Huaxing Pharmaceutical Ampicillin Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 112. Huaxing Pharmaceutical Ampicillin Product Portfolio Table 113. Huaxing Pharmaceutical Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Ampicillin Distributors List Table 117. Ampicillin Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Ampicillin Product Image Figure 2. Global Ampicillin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ampicillin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ampicillin Sales (2021-2032) & (t) Figure 5. Global Ampicillin Sales Average Price (USD/kg) & (2021-2032) Figure 6. Global Ampicillin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Ampicillin Capsules Image Figure 10. Ampicillin Sodium Image Figure 11. Ampicillin Granules Image Figure 12. Ampicillin Tablets Image Figure 13. Ampicillin Sodium for Injection Image Figure 14. Ampicillin Sodium and Sulbactam Sodium for Injection Image Figure 15. Ampicillin Sodium and Cloxacillin Sodium for Injection Image Figure 16. Others Image Figure 17. Global Ampicillin Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 18. Global Ampicillin Sales Volume Share 2021 VS 2025 VS 2032 Figure 19. Global Ampicillin Sales Volume Share by Type (2021-2032) Figure 20. Global Ampicillin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Ampicillin Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Ampicillin Sales Value Share by Type (2021-2032) Figure 23. Adults Image Figure 24. Kids Image Figure 25. Global Ampicillin Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 26. Global Ampicillin Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Ampicillin Sales Volume Share by Application (2021-2032) Figure 28. Global Ampicillin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Ampicillin Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Ampicillin Sales Value Share by Application (2021-2032) Figure 31. Global Ampicillin Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 32. Global Ampicillin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Ampicillin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Ampicillin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Ampicillin Sales Value (2021-2032) & (US$ Million) Figure 36. North America Ampicillin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Ampicillin Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Ampicillin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Ampicillin Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Ampicillin Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Ampicillin Sales Value (2021-2032) & (US$ Million) Figure 42. South America Ampicillin Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Ampicillin Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Ampicillin Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Ampicillin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Ampicillin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Ampicillin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Ampicillin Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Ampicillin Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Ampicillin Capsules
  • Ampicillin Sodium
  • Ampicillin Granules
  • Ampicillin Tablets
  • Ampicillin Sodium for Injection
  • Ampicillin Sodium and Sulbactam Sodium for Injection
  • Ampicillin Sodium and Cloxacillin Sodium for Injection
  • Others
Applications
  • Adults
  • Kids
Companies covered
  • DSM
  • ACS Dobfar
  • Kopran
  • Antibioticos
  • United Laboratories
  • Shandong Lukang
  • CSPC Pharmaceutical
  • North China Pharmaceutical
  • Huaxing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ampicillin Sales Value (2021-2032)
  4. 1.2.2 Global Ampicillin Sales Volume (2021-2032)
  5. 1.2.3 Global Ampicillin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ampicillin Market Dynamics
  1. 2.1 Ampicillin Industry Trends
  2. 2.2 Ampicillin Industry Drivers
  3. 2.3 Ampicillin Industry Opportunities and Challenges
  4. 2.4 Ampicillin Industry Restraints
3 Ampicillin Market by Company
  1. 3.1 Global Ampicillin Company Revenue Ranking in 2025
  2. 3.2 Global Ampicillin Revenue by Company (2021-2026)
  3. 3.3 Global Ampicillin Sales Volume by Company (2021-2026)
  4. 3.4 Global Ampicillin Average Price by Company (2021-2026)
  5. 3.5 Global Ampicillin Company Ranking (2024-2026)
  6. 3.6 Global Ampicillin Company Manufacturing Base and Headquarters
  7. 3.7 Global Ampicillin Company Product Type and Application
  8. 3.8 Global Ampicillin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ampicillin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ampicillin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ampicillin Market by Type
  1. 4.1 Ampicillin Type Introduction
  2. 4.1.1 Ampicillin Capsules
  3. 4.1.2 Ampicillin Sodium
  4. 4.1.3 Ampicillin Granules
  5. 4.1.4 Ampicillin Tablets
  6. 4.1.5 Ampicillin Sodium for Injection
  7. 4.1.6 Ampicillin Sodium and Sulbactam Sodium for Injection
  8. 4.1.7 Ampicillin Sodium and Cloxacillin Sodium for Injection
  9. 4.1.8 Others
  10. 4.2 Global Ampicillin Sales Volume by Type
  11. 4.2.1 Global Ampicillin Sales Volume by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Ampicillin Sales Volume by Type (2021-2032)
  13. 4.2.3 Global Ampicillin Sales Volume Share by Type (2021-2032)
  14. 4.3 Global Ampicillin Sales Value by Type
  15. 4.3.1 Global Ampicillin Sales Value by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Ampicillin Sales Value by Type (2021-2032)
  17. 4.3.3 Global Ampicillin Sales Value Share by Type (2021-2032)
5 Ampicillin Market by Application
  1. 5.1 Ampicillin Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Kids
  4. 5.2 Global Ampicillin Sales Volume by Application
  5. 5.2.1 Global Ampicillin Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Ampicillin Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Ampicillin Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Ampicillin Sales Value by Application
  9. 5.3.1 Global Ampicillin Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Ampicillin Sales Value by Application (2021-2032)
  11. 5.3.3 Global Ampicillin Sales Value Share by Application (2021-2032)
6 Ampicillin Regional Sales and Value Analysis
  1. 6.1 Global Ampicillin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ampicillin Sales by Region (2021-2032)
  3. 6.2.1 Global Ampicillin Sales by Region: 2021-2026
  4. 6.2.2 Global Ampicillin Sales by Region (2027-2032)
  5. 6.3 Global Ampicillin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ampicillin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ampicillin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ampicillin Sales Value by Region (2027-2032)
  9. 6.5 Global Ampicillin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ampicillin Sales Value (2021-2032)
  12. 6.6.2 North America Ampicillin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ampicillin Sales Value (2021-2032)
  15. 6.7.2 Europe Ampicillin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ampicillin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ampicillin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ampicillin Sales Value (2021-2032)
  21. 6.9.2 South America Ampicillin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ampicillin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ampicillin Sales Value Share by Country, 2025 VS 2032
7 Ampicillin Country-level Sales and Value Analysis
  1. 7.1 Global Ampicillin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ampicillin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ampicillin Sales by Country (2021-2032)
  4. 7.3.1 Global Ampicillin Sales by Country (2021-2026)
  5. 7.3.2 Global Ampicillin Sales by Country (2027-2032)
  6. 7.4 Global Ampicillin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ampicillin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ampicillin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ampicillin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ampicillin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ampicillin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ampicillin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ampicillin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ampicillin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ampicillin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ampicillin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ampicillin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ampicillin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ampicillin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ampicillin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ampicillin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ampicillin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ampicillin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ampicillin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ampicillin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ampicillin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ampicillin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ampicillin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ampicillin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ampicillin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ampicillin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ampicillin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ampicillin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ampicillin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ampicillin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ampicillin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ampicillin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ampicillin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ampicillin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ampicillin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ampicillin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ampicillin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ampicillin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ampicillin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ampicillin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ampicillin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ampicillin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ampicillin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ampicillin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ampicillin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ampicillin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ampicillin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ampicillin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ampicillin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ampicillin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ampicillin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ampicillin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ampicillin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ampicillin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ampicillin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ampicillin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ampicillin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ampicillin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ampicillin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ampicillin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ampicillin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ampicillin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ampicillin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ampicillin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ampicillin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ampicillin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ampicillin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ampicillin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ampicillin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ampicillin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ampicillin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ampicillin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ampicillin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ampicillin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ampicillin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ampicillin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ampicillin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ampicillin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ampicillin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ampicillin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ampicillin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ampicillin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ampicillin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ampicillin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ampicillin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ampicillin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ampicillin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 DSM
  2. 8.1.1 DSM Company Information
  3. 8.1.2 DSM Business Overview
  4. 8.1.3 DSM Ampicillin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 DSM Ampicillin Product Portfolio
  6. 8.1.5 DSM Recent Developments
  7. 8.2 ACS Dobfar
  8. 8.2.1 ACS Dobfar Company Information
  9. 8.2.2 ACS Dobfar Business Overview
  10. 8.2.3 ACS Dobfar Ampicillin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ACS Dobfar Ampicillin Product Portfolio
  12. 8.2.5 ACS Dobfar Recent Developments
  13. 8.3 Kopran
  14. 8.3.1 Kopran Company Information
  15. 8.3.2 Kopran Business Overview
  16. 8.3.3 Kopran Ampicillin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Kopran Ampicillin Product Portfolio
  18. 8.3.5 Kopran Recent Developments
  19. 8.4 Antibioticos
  20. 8.4.1 Antibioticos Company Information
  21. 8.4.2 Antibioticos Business Overview
  22. 8.4.3 Antibioticos Ampicillin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Antibioticos Ampicillin Product Portfolio
  24. 8.4.5 Antibioticos Recent Developments
  25. 8.5 United Laboratories
  26. 8.5.1 United Laboratories Company Information
  27. 8.5.2 United Laboratories Business Overview
  28. 8.5.3 United Laboratories Ampicillin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 United Laboratories Ampicillin Product Portfolio
  30. 8.5.5 United Laboratories Recent Developments
  31. 8.6 Shandong Lukang
  32. 8.6.1 Shandong Lukang Company Information
  33. 8.6.2 Shandong Lukang Business Overview
  34. 8.6.3 Shandong Lukang Ampicillin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shandong Lukang Ampicillin Product Portfolio
  36. 8.6.5 Shandong Lukang Recent Developments
  37. 8.7 CSPC Pharmaceutical
  38. 8.7.1 CSPC Pharmaceutical Company Information
  39. 8.7.2 CSPC Pharmaceutical Business Overview
  40. 8.7.3 CSPC Pharmaceutical Ampicillin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 CSPC Pharmaceutical Ampicillin Product Portfolio
  42. 8.7.5 CSPC Pharmaceutical Recent Developments
  43. 8.8 North China Pharmaceutical
  44. 8.8.1 North China Pharmaceutical Company Information
  45. 8.8.2 North China Pharmaceutical Business Overview
  46. 8.8.3 North China Pharmaceutical Ampicillin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 North China Pharmaceutical Ampicillin Product Portfolio
  48. 8.8.5 North China Pharmaceutical Recent Developments
  49. 8.9 Huaxing Pharmaceutical
  50. 8.9.1 Huaxing Pharmaceutical Company Information
  51. 8.9.2 Huaxing Pharmaceutical Business Overview
  52. 8.9.3 Huaxing Pharmaceutical Ampicillin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Huaxing Pharmaceutical Ampicillin Product Portfolio
  54. 8.9.5 Huaxing Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ampicillin Value Chain Analysis
  2. 9.1.1 Ampicillin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ampicillin Sales Mode & Process
  6. 9.2 Ampicillin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ampicillin Distributors
  9. 9.2.3 Ampicillin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst